A California woman has been awarded more than $US70 million ($A92 million) after alleging that years of using Johnson & Johnson’s baby powder caused her cancer.
It’s the latest case raising concerns about the health ramifications of extended talcum powder use.
Full post after cut.....................................
The jury ruling today ended the trial that began September 26 in the case brought by Deborah Giannecchini of Modesto, California.
She was diagnosed with ovarian cancer in 2012.
The suit accused Johnson & Johnson of “negligent conduct” in making and marketing its baby powder.
“We are pleased the jury did the right thing,” said Jim Onder, a lawyer for Giannecchini. “They once again reaffirmed the need for Johnson & Johnson to warn the public of the ovarian cancer risk associated with its product.”
In a statement provided to the St. Louis Post-Dispatch Carol Goodrich, a spokeswoman with Johnson & Johnson, said: “We deeply sympathise with the women and families impacted by ovarian cancer. We will appeal today’s verdict because we are guided by the science, which supports the safety of Johnson’s Baby Powder.”
Earlier this year, two other lawsuits in St Louis ended in jury verdicts worth a combined $US127 million ($A167 million), but two others in New Jersey were thrown out by a judge who said there wasn’t reliable evidence that talc leads to ovarian cancer.
About 2,000 women have filed similar suits, and lawyers are reviewing thousands of other potential cases, most generated by ads touting the two big verdicts out of St. Louis — a $72 million award in February to relatives of an Alabama woman who died of ovarian cancer, and a $55 million award in May to a South Dakota survivor of the disease.
The jury ruling today ended the trial that began September 26 in the case brought by Deborah Giannecchini of Modesto, California.
She was diagnosed with ovarian cancer in 2012.
The suit accused Johnson & Johnson of “negligent conduct” in making and marketing its baby powder.
“We are pleased the jury did the right thing,” said Jim Onder, a lawyer for Giannecchini. “They once again reaffirmed the need for Johnson & Johnson to warn the public of the ovarian cancer risk associated with its product.”
In a statement provided to the St. Louis Post-Dispatch Carol Goodrich, a spokeswoman with Johnson & Johnson, said: “We deeply sympathise with the women and families impacted by ovarian cancer. We will appeal today’s verdict because we are guided by the science, which supports the safety of Johnson’s Baby Powder.”
Earlier this year, two other lawsuits in St Louis ended in jury verdicts worth a combined $US127 million ($A167 million), but two others in New Jersey were thrown out by a judge who said there wasn’t reliable evidence that talc leads to ovarian cancer.
About 2,000 women have filed similar suits, and lawyers are reviewing thousands of other potential cases, most generated by ads touting the two big verdicts out of St. Louis — a $72 million award in February to relatives of an Alabama woman who died of ovarian cancer, and a $55 million award in May to a South Dakota survivor of the disease.
No comments:
Post a Comment